HIV drug reduces Graft-versus-Host Disease in bone marrow transplant patients
An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, researchers the Perelman School of Medicine at the University of Pennsylvania reported. The findings represent a new tactic for the prevention of graft-versus-host disease (GvHD), which afflicts up to [Sign in to read the full article...]
